PO Box 4066 Alice Springs NT 0871
P: +61 8 8951 4700
General Enquiries: remotephcmanuals@flinders.edu.au
This table must be used with protocols from CARPA STM (8th ed) or WBM (7th ed) – it does not provide all the information needed for appropriate treatment.
Notes:
† = other strengths and forms available. Doses in brackets (mL, tab) only apply to forms and strengths listed.
For more information and details on giving medicine see AMH, Therapeutic Guidelines, Australian Injectable Drugs Handbook, Medicines Book.
This table must be used with protocols from CARPA STM (8th ed) or WBM (7th ed) – it does not provide all the information needed for appropriate treatment.
Notes:
† = other strengths and forms available. Doses in brackets (mL, tab) only apply to forms and strengths listed.
For more information and details on giving medicine see AMH, Therapeutic Guidelines, Australian Injectable Drugs Handbook, Medicines Book.
This table must be used with protocols from CARPA STM (8th ed) or WBM (7th ed) – it does not provide all the information needed for appropriate treatment.
Notes:
For more information and details on giving medicine see AMH, Therapeutic Guidelines, Australian Injectable Drugs Handbook, Medicines Book.
This table must be used with protocols from CARPA STM (8th ed) or WBM (7th ed) – it does not provide all the information needed for appropriate treatment.
Notes:
† = other strengths and forms available. Doses in brackets (mL, tab) only apply to forms and strengths listed.
For more information and details on giving medicine see AMH, Therapeutic Guidelines, Australian Injectable Drugs Handbook, Medicines Book.
This table must be used with protocols from CARPA STM (8th ed) or WBM (7th ed) – it does not provide all the information needed for appropriate treatment.
Notes:
For more information and details on giving medicine see AMH, Therapeutic Guidelines, Australian Injectable Drugs Handbook, Medicines Book.
This table must be used with protocols from CARPA STM (8th ed) or WBM (7th ed) – it does not provide all the information needed for appropriate treatment.
Notes:
# Mix with normal saline to give 0.1mg/mL — 1mL with 3mL, 5mL with 15mL
For more information and details on giving medicine see AMH, Therapeutic Guidelines, Australian Injectable Drugs Handbook, Medicines Book.
This table must be used with protocols from CARPA STM (8th ed) or WBM (7th ed) – it does not provide all the information needed for appropriate treatment.
Notes:
† = other forms available. Doses listed only apply to this form.
For more information and details on giving medicine see AMH, Therapeutic Guidelines, Medicines Book.
This table must be used with protocols from CARPA STM (8th ed) or WBM (7th ed) – it does not provide all the information needed for appropriate treatment.
Notes:
† = other strengths and forms available. Doses in brackets (mL, tab) only apply to forms and strengths listed.
For more information and details on giving medicine see AMH, Therapeutic Guidelines, Medicines Book.
This table must be used with protocols from CARPA STM (8th ed) or WBM (7th ed) – it does not provide all the information needed for appropriate treatment.
Notes:
For more information and details on giving medicine see AMH, Therapeutic Guidelines, Medicines Book.
This table must be used with protocols from CARPA STM (8th ed) or WBM (7th ed) – it does not provide all the information needed for appropriate treatment.
Notes:
† = other strengths and forms available. Doses in brackets (mL, tab) only apply to forms and strengths listed.
For more information and details on giving medicine see AMH, Therapeutic Guidelines, Australian Injectable Drugs Handbook, Medicines Book.
This table must be used with protocols from CARPA STM (8th ed) or WBM (7th ed) – it does not provide all the information needed for appropriate treatment.
Notes:
Control bleeding
Control bleeding in postpartum haemorrhage
For more information and details on giving medicine see AMH, Therapeutic Guidelines, Australian Injectable Drugs Handbook, Medicines Book.
This table must be used with protocols from CARPA STM (8th ed) or WBM (7th ed) – it does not provide all the information needed for appropriate treatment.
Notes:
IV or intraosseus – Single dose
Infusion dose per hour
† = other strengths and forms available. Doses in brackets (mL, tab) only apply to forms and strengths listed.
For more information and details on giving medicine see AMH, Therapeutic Guidelines, Australian Injectable Drugs Handbook, Medicines Book.
For more information on using medicines when a woman is pregnant or breastfeeding, contact your closest Pregnancy Drug Information Centre.
Australian categories for use of medicines in pregnancy
'Harm’ means birth defects or other direct or indirect harm to fetus. For more detail see AMH or Therapeutic Guidelines.
Category A: Have been taken by a large number of pregnant women and women of childbearing age
without any known harm
Category B1: Have been taken by a limited number of pregnant women and women of childbearing age
without any known harm. Animal studies have not shown harm
Category B2: Women as for B1. Animal studies are poor quality or lacking, but no evidence of harm
in available data
Category B3: Women as for B1. Animal studies shown some evidence of harm, but not clear if this
is significant for humans
Category C: Have caused or are suspected of causing harm but not malformations. Effects may be
non–permanent
Category D: Have caused or are suspected of causing permanent harm
Category X: Have such a high risk of causing permanent harm that they should not be used in women
who are or could be pregnant
Notes:
PO Box 4066 Alice Springs NT 0871
P: +61 8 8951 4700
General Enquiries: remotephcmanuals@flinders.edu.au